Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
09/16/1998 | EP0863881A1 Benzimidazole derivatives and their use in the prevention and/or the treatment of bone diseases |
09/16/1998 | EP0863769A1 Glycoconjugates as virus cell adhesion inhibitors |
09/16/1998 | EP0863767A2 Powdery iodine complexes |
09/16/1998 | EP0863757A1 2-substituted aryl pyrroles, compositions containing such compounds and methods of use |
09/16/1998 | EP0863753A1 Perfluoroalkyl substituted metallo-beta-lactamase inhibitors and method for the preparation of trifluoromethylketone derivatives |
09/16/1998 | EP0863752A1 Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases |
09/16/1998 | EP0863704A1 Stimulation of cell-mediated immune responses by targeted particulate genetic immunization |
09/16/1998 | EP0756598B1 Substituted 5,6-dihydro-5-oxo-1,4-dithiino-(2,3-d)-pyridazine-2,3-dicarbonitriles, compositions containing them and their use as antimicrobials |
09/16/1998 | EP0661930B1 Viscous liquid xylitol compositions and method for preparing same |
09/16/1998 | EP0624162B1 Novel steroid intermediates and processes for their preparation |
09/16/1998 | EP0598719B1 Receptor conjugates for targeting drugs and other agents |
09/16/1998 | EP0485430B1 Methods and compositions for ameliorating the symptoms of sepsis |
09/16/1998 | CN1193352A Human chitinase, its recombinant production, its use for decomposing chitin, and its use in therapy or prophylaxis against infection diseases |
09/16/1998 | CN1193349A Vaccine for infectious agents, compositions for treating and preventing HIV infections |
09/16/1998 | CN1193324A Acellular pertussis vaccines and method of preparation thereof |
09/16/1998 | CN1193277A Antiviral agents |
09/16/1998 | CN1193276A Use of oxido-squalene cyclase inhibitors to lower blood cholesterol |
09/16/1998 | CN1193023A Indocalamus-leaf polyose sulfate and preparation process therefor |
09/16/1998 | CN1193021A Intermediate compound for synthesizing nucleoside derivative |
09/16/1998 | CN1193013A Modified oligodeoxynucleotide acid |
09/15/1998 | US5808147 Oxidation hydrolysis of the corresponding sulfonated compound |
09/15/1998 | US5808068 HIV nuclear localization inhibitors |
09/15/1998 | US5808062 Aids therapy |
09/15/1998 | US5808047 Blocking; hydrolysis; oxidation |
09/15/1998 | US5808029 Genetic engineering |
09/15/1998 | US5808027 N-2 substituted purines in oligonucleotides |
09/15/1998 | US5808004 Fragments of a lymphocyte adhesion receptor for high endothelium, CD44 |
09/15/1998 | US5807992 Vaccines; medical diagnosis |
09/15/1998 | US5807891 Antiviral ethers of aspartate protease substrate isosteres |
09/15/1998 | US5807890 Antiodor, antimicrobial and preservative compositions and methods of using same |
09/15/1998 | US5807885 Amidine derivatives with nitric oxide synthetase activities |
09/15/1998 | US5807881 Method for selectively reducing activated leukocyte cell population |
09/15/1998 | US5807876 Inosine-5'-monophospate dehydrogenase; viral diseases, cancer, vascular diseases; merimepodib |
09/15/1998 | US5807870 Substituted pipecolinic acid derivatives as HIV protease inhibitors |
09/15/1998 | US5807862 Therapeutic compounds containing pyrimidinyl moieties |
09/15/1998 | US5807859 Antiischemic agents; brain disorders |
09/15/1998 | US5807854 Pyrimidone derivatives with antifungal activity |
09/15/1998 | US5807844 Therapy for septic shock, infections, toxicity |
09/15/1998 | US5807841 HIV protease inhibitors useful for the treatment of AIDS |
09/15/1998 | US5807837 Administering to treat hiv infections to inhibit the replication of foreign nucleic acids in a normal cell |
09/15/1998 | US5807826 Semaphorin gene family |
09/15/1998 | US5807824 C5A receptor antagonists having substantially no agonist activity |
09/15/1998 | US5807757 Controlling particle size distribution |
09/15/1998 | US5807754 Combinatorial synthesis and high-throughput screening of a Rev-inhibiting arylidenediamide array |
09/15/1998 | US5807734 Polypeptide |
09/15/1998 | US5807712 Genetic engineered protein |
09/15/1998 | US5807706 Genetic engineering |
09/15/1998 | US5807702 Genetic engineering |
09/15/1998 | US5807564 Method of strengthening antibacterial action of antibiotics |
09/15/1998 | US5807557 Vaccine |
09/15/1998 | US5807553 Immonogenic oligosaccharide compositions |
09/15/1998 | US5807546 Livestock mucosal competitive exclusion culture to reduce enteropathogenic bacteria |
09/15/1998 | CA2146414C Treatment of h. pylori infections |
09/15/1998 | CA2122815C 2'-deoxy-2'-fluorocoformycin and stereoisomers thereof |
09/15/1998 | CA2029058C Opthalmic fluid dispensing method |
09/15/1998 | CA2025668C Use of omeprazole as an antimicrobial agent |
09/15/1998 | CA2013136C (s)-7-(3-amino-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1, 4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid |
09/15/1998 | CA2006269C 1,4-dideoxy-1,4-imino-l-allitol and its n-substituted alkyl and benzyl derivatives |
09/14/1998 | CA2221830A1 Tumor necrosis factor related receptor, tr6 |
09/13/1998 | CA2199989A1 Expression of a foamy virus envelope protein |
09/11/1998 | WO1998039487A1 Novel screening methods to identify agents that selectively inhibit hepatitis c virus replication |
09/11/1998 | WO1998039463A2 Lentivirus based vector and vector system |
09/11/1998 | WO1998039450A2 SURFACE PROTEIN (SPsA PROTEIN) OF STREPTOCOCCUS PNEUMONIAE, DELETED DERIVATIVES, EXPRESSION SYSTEM FOR SAID PROTEINS AND VACCINE SYSTEM WITH SAID PROTEINS |
09/11/1998 | WO1998039441A1 Human chemokine receptor-like chemokine |
09/11/1998 | WO1998039435A1 Cash (caspase homologue) with death effector domain, modulators of the function of fas receptors |
09/11/1998 | WO1998039426A2 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products |
09/11/1998 | WO1998039360A1 Antigenic structural peptide, antigenic and immunogenic compounds and uses for detecting, preventing and treating an hcv infection |
09/11/1998 | WO1998039352A1 Novel bicyclonucleoside and oligonucleotide analogues |
09/11/1998 | WO1998039311A1 Antibacterial heterocyclic amino acid derivatives |
09/11/1998 | WO1998039033A1 Costimulation of t-cell proliferation by a chimeric bispecific costimulatory protein |
09/11/1998 | WO1998039031A1 Functional dna clone for hepatitis c virus (hcv) and uses thereof |
09/11/1998 | WO1998039030A1 Vaccine composition for preventing or treating c hepatitis |
09/11/1998 | WO1998039028A1 Lyme combination compositions and uses |
09/11/1998 | WO1998039011A1 Photosensitizer conjugates for pathogen targeting |
09/11/1998 | WO1998039007A1 Supression of cyclin kinase 2 activity for prevention and treatment of dna viral infections |
09/11/1998 | WO1998038986A2 Use of carvedilol or derivatives thereof for the manufacture of a medicament for the prevention and treatment of viral infections |
09/11/1998 | WO1998038854A1 Pharmaceutical composition and methods for using it |
09/11/1998 | WO1998030707A3 Eukaryotic gene expression cassette and uses thereof |
09/11/1998 | CA2287531A1 Supression of cyclin kinase 2 activity for prevention and treatment of dna viral infections |
09/11/1998 | CA2284083A1 Antigenic structural peptide, antigenic and immunogenic compounds and uses for detecting, preventing and treating an hcv infection |
09/11/1998 | CA2283379A1 Novel screening methods to identify agents that selectively inhibit hepatitis c virus replication |
09/11/1998 | CA2283300A1 Costimulation of t-cell proliferation by a chimeric bispecific costimulatory protein |
09/11/1998 | CA2283076A1 Vaccine composition for preventing or treating c hepatitis |
09/11/1998 | CA2282760A1 Human chemokine receptor-like chemokine |
09/11/1998 | CA2282717A1 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products |
09/11/1998 | CA2282691A1 Antibacterial heterocyclic amino acid derivatives |
09/11/1998 | CA2281484A1 Cash (caspase homologue) with death effector domain, modulators of the function of fas receptors |
09/11/1998 | CA2231365A1 Bismuth salts of antibiotics of the moenomycin group, processes for their preparation, their use and pharmaceuticals comprising such salts |
09/10/1998 | DE19708537A1 Neues Oberflächenprotein (SpsA-Protein) von Streptococcus pneumoniae etc. New surface protein (SpsA protein) of Streptococcus pneumoniae, etc. |
09/09/1998 | EP0863208A2 Histidine Kinase polypeptides, polynucleotides encluding the same and use thereof |
09/09/1998 | EP0863207A1 RNA dependent amidotransferase A from Staphylococcus Aureus |
09/09/1998 | EP0863139A1 Benzoxazindione derivatives, process for their preparation and their use |
09/09/1998 | EP0862919A1 Remedy for hepatitides |
09/09/1998 | EP0862634A1 Pharmaceutical composition for treating papillomavirus tumours and infection |
09/09/1998 | EP0862633A1 Virus protein antigens of the jc virus |
09/09/1998 | EP0862615A1 Immunity against pasteurella haemolytica leukotoxin |
09/09/1998 | EP0862579A1 Cyclohexapeptidyl bisamine compound, compositions containing said compound and methods of use |
09/09/1998 | EP0862578A1 Actinomycin d analogues |
09/09/1998 | EP0862552A1 Succinimide and maleimide cytokine inhibitors |
09/09/1998 | EP0862458A1 Urease for the treatment of helicobacter pylori infections |